View Author
patient study stent group lesion restenosi trial diameter follow-up angioplasty fluvastatin result argatroban artery level month angiographic placebo event serruy infarction vessel implantation wallstent carvedilol stenting treatment procedure hospital randomized fluvastatin group outcome heparin table heart occlusion balloon length 0.1 angiography cholesterol stenosi analysis balloon angioplasty therapy stent implantation serruys pw magic cardiology effect reduction disease 6 months magic wallstent value randomized study percutaneou death stent length timi grade 2 graft medication baseline dose -®nding study post- intervention luminal circulation rotterdam 0.0 figure percutaneous transluminal 3 ¯ ow post-p 0.4 0.3 placebo group pre-p atherectomy end point
9 Most Recent Publications
|
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial
(Article)
Meier, B. Macaya Miguel, C.M. Serruys, P.W.J.C. Kokott, N. Puel, J. Vrolix, M.C. Branzi, A. Bertolami, M.C. Jackson, G. Strauss, B.H. Feyter, P.J. de |
2002-01-01
|
|
The influence of stent length on clinical and angiographic outcome in patients undergoing elective stenting for native coronary artery lesions; final results of the Magic 5L Study
(Article)
Foley, D.P. Pieper, M. Bonnier, J.J.R.M. Colombo, A. Thomas, M. Probst, P. Morice, M-C. Kleijne, J. Serruys, P.W.J.C. Wijns, W. Suryapranata, H. Grollier, G. Legrand, V.M.G. Scheerder, I.K. de Hanet, C. Puel, J. Mudra, H. |
2001-09-12
|
|
Argatroban and alteplase in patients with acute myocardial infarction: the ARGAMI study
(Article)
Vermeer, F. Vahanioan, A. Werf, F.J.J. van de Fels, P.W. Besse, P. Muller, E. Fitzgerald, D. Darius, H. Puel, J. Garrigou, D. Simoons, M.L. |
2000-01-01
|
|
Carvedilol for prevention of restenosis after directional coronary atherectomy : final results of the European carvedilol atherectomy restenosis (EUROCARE) trial
(Article)
Puel, J. Montauban van Swijndregt, E.W.J. Katus, H.A. Wijns, W. Melkert, R. Bonnier, J.J.R.M. Hofling, B. Serruys, P.W.J.C. Foley, D.P. Glogar, H.D. Seabra-Gomes, R. Goicolea, J. Hauf-Zachariou, U. Simon, R. Coste, P. Rutsch, W.R. Betriu, A. |
2000-01-01
|
|
Quantitative angiographic follow-up of the coronary wallstent in native vessels and bypass grafts (European experience - March 1986 to March 1990)
(Article)
Strauss, B.H. Serruys, P.W.J.C. Montauban van Swijndregt, E.W.J. Bertrand, M.E. Puel, J. Meier, B. Goy, J-J. Kappenberger, L. Rickards, A.F. Sigwart, U. Morel, M-A.M. |
1992-01-01
|
|
Angiographic follow-up after placement of a self-expanding coronary artery stent
(Article)
Serruys, P.W.J.C. Strauss, B.H. Sigwart, U. Beatt, K.J. Bertrand, M.E. Puel, J. Rickards, A.F. Meier, B. Goy, J-J. Vogt, P. Kappenberger, L. |
1991-01-01
|
|
Relative risk analysis of angiographic predictors of restenosis within the coronary Wallstent
(Article)
Strauss, B.H. Serruys, P.W.J.C. Sigwart, U. Scheerder, I.K. de Tijssen, J.G.P. Bertrand, M.E. Puel, J. Meier, B. Kaufmann, U. Stauffer, J.C. Rickards, A.F. |
1991-01-01
|
|
Early and late assessment in stenotic geometry after coronary arterial stenting
(Article)
Puel, J. Juillière, Y. Bertrand, M.E. Rickards, A.F. Sigwart, U. Serruys, P.W.J.C. |
1988-01-01
|
|
Additional improvement of stenosis geometry in human coronary arteries by stenting after balloon dilatation
(Article)
Serruys, P.W.J.C. Juillière, Y. Bertrand, M.E. Puel, J. Rickards, F. Sigwart, U. |
1988-01-01
|
